Amin Khan - 10 May 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC

Role
Chief Scientific Officer
Signature
/s/ David Kennedy, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 May 2022
Net transactions value
$0
Form type
4
Filing time
08 Aug 2022, 10:15:11 UTC
Previous filing
04 Feb 2022
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRNA Stock Option (Right to Buy) Award $0 +318,751 $0.000000 318,751 10 May 2022 Common Stock 318,751 $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on the first anniversary of the grant date and the remainder of the shares shall vest in 36 equal monthly installments thereafter.